Tejas Adiga
Partner - Corporate
Healthcare & Life Science | Cross-border Transactions | Joint Ventures | Mergers and Acquisitions
Overview
Tejas Adiga is a Partner, based out of Trilegal’s Mumbai office, and a part of the Corporate practice group. Tejas’ practice area covers cross-border and domestic merger and acquisition transactions, joint ventures and strategic alliances, spinoffs and divestitures of business divisions, and corporate restructuring.
Tejas has had extensive experience representing an array of clients, including international conglomerates, Indian companies, private equity firms, financial sponsors and governmental institutions. He has advised on a wide range of corporate transactions and matters, particularly in the oil and gas, petrochemicals, renewable energy, automobiles, pharmaceutical and financial services sectors.
In the healthcare and life sciences sector, Tejas has represented clients in mergers and acquisitions, joint ventures, business disposal/restructuring transactions, and in-licensing or collaboration development arrangements. He also advises on the export/import of medical devices, the development of commercial molecules, and related regulatory matters.
Some of his key clients are Viatris Inc, Glenmark Pharmaceutical Ltd, Rosneft Oil Company OJSC, British Petroleum, Fosun Group, Weichai Power Company, Shandong Heavy Industries, Orix Group, Abu Dhabi Investment Authority, Public Sector Pension Investment Board, Asian Development Bank, Glenmark Pharmaceutical Ltd, Azelis S.A., Nayara Energy Ltd, SBI Funds Management and ICICI Bank.
Education
ILS Law College, Pune
Admissions
Bar Council of Karnataka
Select representative clients/matters
- Goldman Sachs, on its investment in Aragen Life Sciences
- Glenmark Pharmaceuticals, API business restructuring and majority divestment to Nirma Limited
- EQT and Azelis Group S.A, on their respective investments into Indian companies engaged in pharmaceuticals, specialty chemicals and excipients business
- Orix Financial Corporation, on its global acquisition of Robeco Investments
- Rosneft Oil Company, on its USD 12.9-billion equity investment in Essar Oil Ltd, with a consortium of investors
